Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
546
datasets available to search
ShareScore release 0.9.0
Dataset results
546 results for “Predictive biomarkers”
Data from: Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma
Purpose: Diagnosis of malignant mesothelioma is challenging. The first available diagnostic material is often an effusion and biochemical analysis of soluble markers may provide additional diagnostic information. This study aimed to establish a predictive model using biomarkers from pleural effusions, to allow early and accurate diagnosis. Patients and Methods: Effusions were collected prospectively from 190 consecutive patients at a regional referral centre. Hyaluronan, N-ERC/mesothelin, C-ERC/mesothelin, osteopontin, syndecan-1, syndecan-2, and thioredoxin were measured using ELISA and HPLC. A predictive model was generated and validated using a second prospective set of 375 effusions collected consecutively at a different referral centre. Results: Biochemical markers significantly associated with mesothelioma were hyaluronan (odds ratio, 95% CI: 8.82, 4.82–20.39), N-ERC/mesothelin (4.81, 3.19–7.93), CERC/mesothelin (3.58, 2.43–5.59) and syndecan-1 (1.34, 1.03–1.77). A two-step model using hyaluronan and N-ERC/mesothelin, and combining a threshold decision rule with logistic regression, yielded good discrimination with an area under the ROC curve of 0.99 (95% CI: 0.97–1.00) in the model generation dataset and 0.83 (0.74–0.91) in the validation dataset, respectively. Conclusions: A two-step model using hyaluronan and N-ERC/mesothelin predicts mesothelioma with high specificity. This method can be performed on the first available effusion and could be a useful adjunct to the morphological diagnosis of mesothelioma.
Identification of Potential Biomarkers for Cerebral Palsy and the Development of Prediction Models
Open the record for dataset details and reuse information.
Analysis of opposing histone modifications H3K4me3 and H3K27me3 reveals candidate diagnostic biomarkers for triple negative breast cancer and gene set prediction combinations
<p>Supplementary data of manuscript <strong>'Analysis of opposing histone modifications H3K4me3 and H3K27me3 reveals candidate diagnostic biomarkers for triple negative breast cancer and gene set prediction combinations </strong><strong>Analysis of opposing histone modifications H3K4me3 and H3K27me3 reveals candidate diagnostic biomarkers for triple negative breast cancer and gene set prediction combinations'</strong></p>
Subnetwork representation learning for discovering network biomarkers in predicting lymph node metastasis in early oral cancer
<p>Dataset for the specified study.</p>
Supplementary to "Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning - a retrospective multicentric study"
<p>High-resolution images of heatmaps. Top tiles and GradCam of figure 5</p>
Novel M2-like tumor-associated macrophage-related biomarkers predict prognosis of Acute myeloid leukemia patients.
<p>The supplementary material for the Novel M2-like tumor-associated macrophage-related biomarkers predict prognosis of Acute myeloid leukemia patients.</p>
Underlying dataset for the manuscript titled "Identification of RTS,S/AS01 vaccine-induced humoral biomarkers predictive of protection against controlled human malaria infection"
<p><span>The antibody binding data included in this dataset is associated with the manuscript “Spreng, R.L., Seaton, K.E. et al., <em><span>Identification of RTS,S/AS01 vaccine-induced humoral biomarkers predictive of protection against controlled human malaria infection; </span></em><span>Accepted for Publication in JCI Insight (2024)</span>. These data come from the characterization of serum samples from four controlled human malaria infection (CHMI) clinical trials of the RTS,S vaccine, including NCT01366534 (referred to as MAL068), NCT01857869 (referred to as MAL071), NCT03162614 (referred to as MAL092), and NCT03824236 (referred to as MAL102).</span></p>
Predictive Value of Coronary Heart Disease (CHD) Biomarkers for CHD Death
ClinicalTrials.gov study NCT01864122. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma
ClinicalTrials.gov study NCT05705583. IPD Sharing: NO. Countries: 1. Publications: 3.
Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy
ClinicalTrials.gov study NCT03578185. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Renal Arterial Resistive Index Versus Novel Biomarkers for Early Prediction of Sepsis Associated-acute Kidney Injury
ClinicalTrials.gov study NCT03799159. IPD Sharing: NO. Countries: 1. Publications: 13.
Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
ClinicalTrials.gov study NCT07224841. IPD Sharing: NO. Countries: 1. Publications: 15.
A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC Patients
ClinicalTrials.gov study NCT03486119. IPD Sharing: NO. Countries: 1. Publications: 1.
Biomarkers to Predict CRT Response in Patients With HF (BIOCRT)
ClinicalTrials.gov study NCT01949246. IPD Sharing: Not stated. Countries: 1. Publications: 3.
ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO)
ClinicalTrials.gov study NCT03322696. IPD Sharing: Not stated. Countries: 1. Publications: 13.
Identification of Predictive Biomarkers
ClinicalTrials.gov study NCT04324983. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)
ClinicalTrials.gov study NCT01566279. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient
ClinicalTrials.gov study NCT04341792. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
ClinicalTrials.gov study NCT03414827. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination of Predictive Biomarkers to Increase Diagnostics Efficiency of Autism Spectrum Disorder
ClinicalTrials.gov study NCT05796310. IPD Sharing: Not stated. Countries: 1. Publications: 15.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.